Qube Research & Technologies LTD Pds Biotechnology Corp Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 8,947 shares of PDSB stock, worth $29,435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,947Holding current value
$29,435% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding PDSB
# of Institutions
76Shares Held
5.42MCall Options Held
155KPut Options Held
61.7K-
Vanguard Group Inc Valley Forge, PA1.41MShares$4.64 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny381KShares$1.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA378KShares$1.24 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$1.13 Million0.18% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $93.6M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...